• Scaling R&D Drug Discovery: The Future Of Lab Automation

    Bio-IT World | In the coming decades, many of the grand challenges that society faces, from global food shortages to disease control and climate change, has the opportunity to be solved by biology. To achieve this, we must enable researchers within the biotech and healthcare ecosystems to be more productive than ever by improving scale, reproducibility, and accessibility.

    Sep 8, 2023

  • Illumina Names Jacob Thaysen of Agilent New CEO

    Bio-IT World | Illumina today announced that its Board of Directors has appointed Jacob Thaysen, Ph.D., senior vice president of Agilent Technologies and president of its Life Sciences and Applied Markets Group, as Illumina’s next Chief Executive Officer, effective September 25, 2023.

    Sep 5, 2023

  • Novel Biomarker Tracks Tightly With Tau Tangles In Alzheimer’s Disease

    Bio-IT World | Researchers in the U.S. and Sweden have identified a biomarker (MTBR-tau243) for Alzheimer’s disease that tracks with the amount of damaging tau tangles in the brain and, when combined with a specific phosphorylated tau species (p-tau205), is nearly as predictive of cognitive function as tau-positron emission tomography (tau-PET) imaging.

    Sep 5, 2023

  • Nanopore News from Oxford Nanopore, University of Missouri, New Genedata Product, More

    Bio-IT World | University of Missouri researchers developed an innovative method using nanopores; Oxford Nanopore speeds basecalling for MinKNOW; Standigm and Nashville Biosciences partner on early drug discovery research, and more.

    Aug 31, 2023

  • The First Commercial-Scale IDMO Smart Factory, Company Advancements, RNA Editing Platforms, More

    Bio-IT World | Cellares will use funding to launch the world’s first commercial-scale IDMO Smart Factory; Genesis Therapeutics plans to use Series B financing to elevate into a clinical stage company and further invest in its AI platform; Amber Bio will use funds to advance first-of-its-kind RNA editing platform; more.

    Aug 30, 2023

  • The Future of Innovation, Generative AI, and More with Jeanne Kehren

    Bio-IT World | When the first human genome was sequenced, Jeanne Kehren switched from veterinary medicine to the pharmaceutical industry. After that “magical moment of hope,” Kehren and her colleagues looked forward to a bright future for individualized medicine and treatment.

    Aug 29, 2023

  • AbbVie’s R&D Convergence Hub

    Bio-IT World | The AbbVie R&D Convergence Hub, known as the ARCH, was conceived in 2020 and already the data platform is breaking silos and improving productivity.

    Aug 24, 2023

  • Neurosurgeons In Czech Republic Test Writing Capabilities Of ChatGPT

    Bio-IT World | Researchers in the Czech Republic succeeded in using ChatGPT (Chat Generative Pre-trained Transformer) to produce a convincing scientific article in only one hour with no special human training—a feat intended to point out the current capabilities of large language models (LLMs).

    Aug 23, 2023

  • Gero Taps Quantum Computing and AI To Tackle Diseases Of Aging

    Bio-IT World | A movement is afoot to apply quantum computing to the puzzling business of designing drugs with the right molecular properties.

    Aug 22, 2023

  • Demographics Matter Under New Diagnostic Paradigm For Breast Cancer

    Bio-IT World | In a surprising twist, researchers at Sanford Burnham Prebys have found that both age and sex may matter a great deal when it comes to the consequences of many types of cancer.

    Aug 17, 2023

  • Nanopore Sequencing Detects Protein Structures

    Bio-IT World | University of Oxford researchers have detected protein structure modifications using nanopore technology.

    Aug 16, 2023

  • Researchers Close In On Protein Panel For Predicting Islet Autoimmunity

    Bio-IT World | A team of researchers from North America and Europe have identified a panel of 83 markers in the blood of children genetically predisposed to develop type 1 diabetes that looks promising as a predictor of which individuals will progress to islet autoimmunity six months prior to its onset.

    Aug 15, 2023

  • New Illumina CTO, Q2 Updates

    Bio-IT World | Illumina today announced that Alex Aravanis, CTO, has departed Illumina to pursue an opportunity outside of the company effective immediately. In his place, Steven Barnard, Illumina's Vice President and Head of Global Advanced Science, will serve as its next Chief Technology Officer (CTO).

    Aug 9, 2023

  • Using ML to Diagnose Chronic Kidney Disease in a Bias-Free, Privacy-Protecting, Physician-Friendly Manner

    Bio-IT World | Carenostics is a healthcare AI startup founded with the mission of addressing the underdiagnosis, undertreatment, and health inequities of chronic disease using AI and ML on existing healthcare data.

    Aug 9, 2023

  • Generate Biomedicines’ R&D Data Platform to Support ML-Driven Drug Discovery

    Bio-IT World | “Generate Biomedicines’ goal of leveraging machine-learning powered generative biology to discover and develop new drugs faster and cheaper is supported by an integrated and cohesive R&D data platform… FAIR to its core, this integrated data platform leverages industry best practices and lessons-learned from a talented team of informatics engineers to form the critical foundation of a unique company with equal parts ‘bio’ and ‘tech’.”

    Aug 8, 2023

  • An AI Tool for Lung Cancer Diagnosis in Indian Populations, Settings

    Bio-IT World | The prognosis of lung carcinoma has changed since the discovery of molecular targets and their specific drugs. Somatic EGFR mutations have been reported in lung carcinoma, and these mutant proteins act as substrates for targeted therapies.

    Aug 3, 2023

  • Discovery To Creation: Highlights from the 2023 Single-Cell and AI in Medicine Symposium

    Bio-IT World | The field of drug discovery is shifting its approach from viewing complex biology as something to be overcome using reductionist principles to something to embrace in a more holistic approach to cell biology.

    Aug 2, 2023

  • Platform Reduces Barriers Biologists Face In Accessing Machine Learning

    Bio-IT World | A group of scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University and MIT are convinced that automated machine learning (autoML) is going to revolutionize biology by removing many of the technical barriers to using computational models to answer fundamental questions about sequences of nucleic acids, peptides, and glycans.

    Aug 1, 2023

  • Illumina Announces New Genomics Alliance, Software for Analyzing Genomic Data, Understanding Disease Molecules, More

    Bio-IT World | Illumina announces the five founding members of the Alliance of Genomic Discovery and launches the newest version of DRAGEN software, the Allen Institute for Immunology and Eli Lilly team up to better understand disease molecules, and crowd-sourced neuroscience. Plus, product updates, partnerships, and acquisitions from Sinequa, Lifebit, Arrayjet, BioIVT, and more.

    Jul 27, 2023

  • Follow the Money: AI Platform for Acute Immune States, Acquisitions, Expanding Solutions Portfolio

    Bio-IT World | AI platform used for acute immune states, acquisitions, solutions portfolio expansion, and more.

    Jul 26, 2023